Nuclear Imaging Devices Market to hit USD 4.6 billion by 2032, says Global Market Insights Inc.


Nuclear Imaging Devices Industry is projected to witness a CAGR of 4.9% during the period 2023-2032. This growth can be attributed to the growing prevalence of chronic diseases worldwide.

Selbyville, Delaware, Aug. 22, 2023 (GLOBE NEWSWIRE) —

Nuclear Imaging Devices Market size is expected to be worth USD 4.6 billion by 2032. The industry trends are driven by the rising incidence of chronic diseases. Various ailments such as cardiovascular disorders, cancer, and neurological disorders require accurate diagnostic tools.


Request for a sample of this research report @

Nuclear imaging devices, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), provide valuable insights into the functioning of organs and tissues, aiding in the early detection and monitoring of various diseases. Moreover, significant advancements in nuclear imaging technology have led to improved resolution, sensitivity, and overall performance of these devices. The development of hybrid imaging systems, such as PET/CT and SPECT/CT, which combine the anatomical information from computed tomography (CT) with the functional information from nuclear imaging, has been a game-changer in diagnostic imaging.

Preference for personalized medicine to fuel demand for PET scans

Nuclear imaging devices market is divided into positron emission tomography (PET), planar scintigraphy, single photon emission computed tomography (SPECT), and others. The positron emission tomography (PET) segment will favor the industry development through 2032. PET provides functional information about organs and tissues, enabling early disease detection and accurate staging. This is particularly valuable in the field of oncology, where PET scans aid in identifying tumor locations, evaluating treatment response, and detecting potential recurrence. This type of imaging is crucial for personalized medicine, as it allows for the evaluation of treatment efficacy based on an individual’s unique physiology. Inclination for tailored treatment among patients as well as medical practitioners will boost the segment development.

Need for accurate diagnosis in Cardiology driving product uptake

The nuclear imaging devices market is bifurcated into cardiology, oncology, neurology, and others. The cardiology segment is expected to generate product demand during 2023 and 2032. Cardiology extensively utilizes nuclear imaging devices for various diagnostic and therapeutic purposes. Nuclear imaging techniques such as Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) play a crucial role in evaluating cardiac function, myocardial perfusion, and viability. These imaging modalities enable the assessment of blood flow, detection of ischemic heart disease, identification of areas with reduced blood supply, and evaluation of myocardial viability after a heart attack. Additionally, nuclear imaging devices help in diagnosing and managing cardiac conditions like coronary artery disease, cardiomyopathies, and heart failure.

Improving healthcare access in APAC region

Regionally, Asia Pacific nuclear imaging devices market has experienced significant increase in recent years. Factors such as increasing healthcare expenditure, advancements in medical technology, and a growing geriatric population are contributing to industry expansion. There is a rise in the prevalence of chronic diseases, leading to an increased demand for accurate diagnostic tools. Governments in countries like China, Japan, and India are investing in healthcare infrastructure, which along with favorable reimbursement policies and ongoing R&D activities will drive the adoption of nuclear imaging devices in the region.

Request for Report Customization @

Nuclear Imaging Devices Market players

Some leading industry players are Absolute Imaging Inc., CANON MEDICAL SYSTEMS CORPORATION, DIGIRAD Corporation, Neusoft Corporation, SurgicEye GmbH, Lucerno Dynamics, LLC., CMR Naviscan., Bartec Technologies Ltd., Berthold Technologies GmbH & Co.KG, GE Healthcare, Incom Inc., Koninklijke Philips N.V., Siemens Healthineers AG among others.

Partial Table of Contents (ToC) of the report:

Chapter 3 Nuclear Imaging Devices Industry Insights

3.1 Industry ecosystem analysis

3.2 Industry impact forces

3.2.1 Growth drivers Growing prevalence of chronic diseases worldwide Rising technological advancements in nuclear imaging systems Rise in healthcare expenditure Favourable government initiatives

3.2.2 Industry pitfalls & challenges High cost of the nuclear imaging devices Lack of skilled or trained personnel in the developing and underdeveloped region

3.3 Growth potential analysis

3.3.1 By product type

3.3.2 By application

3.3.3 By end-use

3.4 COVID-19 impact analysis

3.5 Technology landscape

3.6 Regulatory landscape

3.6.1 U.S.

3.6.2 Europe

3.7 Porter’s analysis

3.8 PESTEL analysis

Chapter 4 Competitive landscape, 2022

4.1 Introduction

4.2 Company matrix analysis, 2022

4.3 Competitive dashboard, 2022

4.4 Company market share analysis, 2022

4.5 Competitive analysis of major market players

4.6 Competitive positioning matrix

4.7 Strategic outlook matrix

Browse Our Reports Store – GMIPulse @

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: [email protected] Read More News @

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.